Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women

BACKGROUND: Daily, oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as pre-exposure prophylaxis (PrEP) reduces HIV acquisition for African women. Adherence is key to efficacy and patterns of adherence can be highly variable in real-world settings. Using group-based trajectory modeling (GBT...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurwitz, Kathleen E., Isehunwa, Oluwaseyi O., Hendrickson, Kayla R., Jaggernath, Manjeetha, Kriel, Yolandie, Smith, Patricia M., Mathenjwa, Mxolisi, Bennett, Kara, Psaros, Christina, Baeten, Jared M., Bangsberg, David R., Haberer, Jessica E., Smit, Jennifer A., Matthews, Lynn T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Reproductive Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582627/
https://www.ncbi.nlm.nih.gov/pubmed/37860779
http://dx.doi.org/10.3389/frph.2023.1263422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582627/
https://www.ncbi.nlm.nih.gov/pubmed/37860779
http://dx.doi.org/10.3389/frph.2023.1263422

Ejemplares similares